Search by Drug Name or NDC

    NDC 30142-0447-14 Fexofenadine HCl and Pseudoephedrine HCI 60; 120 mg/1; mg/1 Details

    Fexofenadine HCl and Pseudoephedrine HCI 60; 120 mg/1; mg/1

    Fexofenadine HCl and Pseudoephedrine HCI is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by The Kroger Co.. The primary component is FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 30142-0447
    Product ID 30142-447_87210e6e-8312-9d26-4381-b6836b9ab254
    Associated GPIs
    GCN Sequence Number 036868
    GCN Sequence Number Description fexofenadine/pseudoephedrine TAB ER 12H 60MG-120MG ORAL
    HIC3 Z2O
    HIC3 Description 2ND GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION
    GCN 63565
    HICL Sequence Number 016846
    HICL Sequence Number Description FEXOFENADINE HCL/PSEUDOEPHEDRINE HCL
    Brand/Generic Generic
    Proprietary Name Fexofenadine HCl and Pseudoephedrine HCI
    Proprietary Name Suffix n/a
    Non-Proprietary Name Fexofenadine HCl and Pseudoephedrine HCI
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 60; 120
    Active Ingredient Units mg/1; mg/1
    Substance Name FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name The Kroger Co.
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076667
    Listing Certified Through 2024-12-31

    Package

    NDC 30142-0447-14 (30142044714)

    NDC Package Code 30142-447-14
    Billing NDC 30142044714
    Package 4 BLISTER PACK in 1 CARTON (30142-447-14) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2015-04-22
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL cb9e98a9-74e6-7a3e-9c5e-3bc35c4bbca6 Details

    Revised: 12/2017